News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..
Photo taken from Nalee Kim/Twitter
Oct 15, 2023, 13:12

Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..

Nalee Kim, Radiation oncologist at Yonsei Cancer Center, shared on X/Twitter:

“We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes.. especially for patients in < 3 lines of systemic Tx and stable extra-breast disease.!”

Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..

For details click here.
Source: Nalee Kim/Twitter

cancer Nalee Kim OncoDaily Oncology primary breast tumor
Special Coverage
Celebrities
Nov 19, 2024, 18:15
Rudy Giuliani and Prostate Cancer: How He Went Against, How He Survived, and More
Blog
Nov 19, 2024, 16:26
ERN PaedCan and Young SIOPE webinar on treatment toxicity in an adolescent with TLL
Blog
Nov 19, 2024, 15:21
Julie S. Torode: WHO launches new target product profiles for HPV screening for cervical cancer
Positive
Nov 19, 2024, 15:20
SIOG’s New Board of Directors for 2024-2026
Blog
Nov 19, 2024, 15:17
Miriam Mutebi: Is it time for you to get screened?
Blog
Nov 19, 2024, 15:14
Aaron Goodman: What is an "M protein"
Blog
Nov 19, 2024, 15:12
The ACS announced the inaugural Food is Medicine in Oncology Care Symposium
Blog
Nov 19, 2024, 15:08
Dinesh Pendharkar: Expanding access to Cancer Care to class of Healthcare Specialists from across the Globe
Blog
Nov 19, 2024, 15:00
NRG-GU010 is approaching the accrual target for the intensification cohort
Insight
Nov 19, 2024, 14:54
Sarcopenia and inflammation predict poorer outcomes in Cancer Immunotherapy
Blog
Nov 19, 2024, 14:46
Boris Pasche: Enjoyed Presenting Our Work at the Cancer Thrivers Network for Jewish Women
Blog
Nov 19, 2024, 14:42
BCNA at the 2024 COSA Annual Scientific Meeting